Our current understanding of human cancers highlights the importance of aberrant developmental programs in cancer pathogenesis. The Development and Cancer Scientific Program (DCSP) brings together invesfigators in the related fields of cancer biology, stem cell biology and developmental biology as a means of exploiting and focusing upon cancer the diverse strengths at UT Southwestern (UTSW) in developmental biology. The three scientific goals of the program are to: 1) Define the interactions between malignant tumor cells and their local environment: Clinicians have long appreciated that particular tumors metastasize to particular sites, suggesfing that tumor cells depend upon specific interactions with normal tissues for their establishment, growth and survival. In addition, epidemiological evidence suggests that other host factors such as obesity are linked with increased cancer risk, through unknown mechanisms. Emerging discoveries are beginning to highlight interacfions between cancer cells and normal host tissues, and a major goal of the DCSP is to define these host-tumor cell interactions at a molecular level with the goal of developing novel and more effective treatments. Program interest is focused in three areas: adiposity and breast cancer, host-tumor interacfion in gliomagenesis and neurofibromatosis, and targefing tumor vasculature. 2) Reveal the molecular mechanisms that confer upon stem cells and cancer stem cells their unique and remarkable properties of self-renewal and pluripotency: There is growing expertise in stem cell biology at UTSW that is harnessed within the program to define the genefic, epigenefic and cell-signaling mechanisms that confer upon stem cells and cancer stem cells their essential characterisfics of pluripotency and capacity for self-renewal. Within the broader research topics represented in the Scientific Programs, the particular strength of the DCSP is its focus on study in living animals, including mouse models. 3) Enhance scientific interactions between clinical investigators and basic scientists to stimulate cancer-focused basic research and clinical translation of research discoveries: Insights revealed by basic research drive new approaches towards cancer treatment, and clinical observations and materials provide opportunifies for important discoveries that will improve treatment of cancer. Physician-scientists within the DCSP are leading projects that focus upon in vivo models of cancer, and choose their research questions with first-hand knowledge of clinical relevance. The Cancer Center leadership and the DCSP lower the acfivation energy of productive interacfion between clinical invesfigators and basic scientists to generate cancer-focused discoveries.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA142543-02
Application #
8305118
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2011-08-01
Budget End
2012-07-31
Support Year
2
Fiscal Year
2011
Total Cost
$20,350
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Rashdan, Sawsan; Minna, John D; Gerber, David E (2018) Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy. Lancet Respir Med 6:472-478
Wijayatunge, Ranjula; Holmstrom, Sam R; Foley, Samantha B et al. (2018) Deficiency of the Endocytic Protein Hip1 Leads to Decreased Gdpd3 Expression, Low Phosphocholine, and Kypholordosis. Mol Cell Biol 38:
Hamann, Heidi A; Shen, Megan J; Thomas, Anna J et al. (2018) Development and Preliminary Psychometric Evaluation of a Patient-Reported Outcome Measure for Lung Cancer Stigma: The Lung Cancer Stigma Inventory (LCSI). Stigma Health 3:195-203
Miyata, Naoteru; Morris, Lindsey L; Chen, Qing et al. (2018) Microbial Sensing by Intestinal Myeloid Cells Controls Carcinogenesis and Epithelial Differentiation. Cell Rep 24:2342-2355
Mokdad, Ali A; Xie, Xian-Jin; Zhu, Hong et al. (2018) Statistical justification of expansion cohorts in phase 1 cancer trials. Cancer 124:3339-3345
Murphy, Caitlin C; Singal, Amit G; Baron, John A et al. (2018) Decrease in Incidence of Young-Onset Colorectal Cancer Before Recent Increase. Gastroenterology 155:1716-1719.e4
Barnes, Arti; Betts, Andrea C; Borton, Eric K et al. (2018) Cervical cancer screening among HIV-infected women in an urban, United States safety-net healthcare system. AIDS 32:1861-1870
Murphy, Caitlin C; Fullington, Hannah M; Alvarez, Carlos A et al. (2018) Polypharmacy and patterns of prescription medication use among cancer survivors. Cancer 124:2850-2857
McMillan, Elizabeth A; Ryu, Myung-Jeom; Diep, Caroline H et al. (2018) Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer. Cell 173:864-878.e29
Zhang, Shuyuan; Nguyen, Liem H; Zhou, Kejin et al. (2018) Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration. Gastroenterology 154:1421-1434

Showing the most recent 10 out of 501 publications